Showing 44,921 - 44,940 results of 112,387 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( a ((point decrease) OR (fold decrease)) ))', query time: 1.79s Refine Results
  1. 44921

    Supplementary Material for: Urinary Apolipoprotein C3 Is a Potential Biomarker for Alzheimer’s Disease by Watanabe Y. (4129684)

    Published 2020
    “…We previously reported on the comprehensive profile of the urinary proteome of AD patients and identified proteins estimated to be significantly increased or decreased in AD patients by a label-free quantification method. …”
  2. 44922

    Effects of the AMPA Antagonist ZK 200775 on Visual Function: A Randomized Controlled Trial by Richard Bergholz (244473)

    Published 2010
    “…<div><h3>Background</h3><p>ZK 200775 is an antagonist at the α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor and had earned attention as a possible neuroprotective agent in cerebral ischemia. …”
  3. 44923

    Speed of processing training and depression in assisted and independent living: A randomized controlled trial by Marianne Smith (7512284)

    Published 2019
    “…Participants were randomized within sites to computerized SOPT vs. computerized crossword puzzles with a targeted dose of 10 hours of playtime at baseline plus 4 hours of booster training at five and eleven months. …”
  4. 44924

    Marcksb plays a key role in the secretory pathway of zebrafish Bmp2b by Ding Ye (405963)

    Published 2019
    “…In contrast, the MZ<i>marcksb</i> embryos even showed increased BMP signaling activity as measured by expression of BMP targets, phosphorylated Smad1/5/9 levels and imaging of Bmp2b, suggesting that a phenomenon of “genetic over-compensation” arose. …”
  5. 44925

    Table 1_Obinutuzumab in systemic lupus erythematosus: a real-world experience.docx by Chunmei Wu (3202050)

    Published 2025
    “…Objectives<p>To describe the real-world efficacy and safety of obinutuzumab in a heterogeneous systemic lupus erythematosus (SLE) population, including severe or refractory manifestations.…”
  6. 44926

    Image6_A Role of Caveolae in Trabecular Meshwork Mechanosensing and Contractile Tone.JPEG by Michael L. De Ieso (12254687)

    Published 2022
    “…Treatment with the Cav1 scaffolding domain mimetic, cavtratin (1 μM) caused a reduction in pMLC (70 ± 5% n = 7, p = 0.001), as did treatment with the scaffolding domain mutant cavnoxin (1 μM) (82 ± 7% n = 7, p = 0.04). …”
  7. 44927

    Supplementary Material for: Cigarette Smoking and the Risk of Cutaneous Melanoma: A Case-Control Study by Sondermeijer L. (7362845)

    Published 2019
    “…<b><i>Objective:</i></b> Previous studies regarding cigarette smoking causing a lower risk of melanoma are inconclusive. Here, we re-examined melanoma risk in relation to cigarette smoking in a large, case-control study. …”
  8. 44928

    Serotonin, a downstream effector of GLP-2, enhances lacteal contractility and lymph flow by Lili Tian (12992016)

    Published 2025
    “…We also examined the role of VEGFR3 as an intermediate in the signaling cascade. Utilizing a rat lymph fistula model, 5 hours after an intraduodenal (i.d.) lipid bolus, the following intraperitoneal (i.p.) administrations were applied in two different sets of experiments: Experiment 1: 1) Placebo, 2) GLP-2, 3) GLP-2 + Ketanserin (serotonin receptor antagonist). …”
  9. 44929

    Image1_A Role of Caveolae in Trabecular Meshwork Mechanosensing and Contractile Tone.JPEG by Michael L. De Ieso (12254687)

    Published 2022
    “…Treatment with the Cav1 scaffolding domain mimetic, cavtratin (1 μM) caused a reduction in pMLC (70 ± 5% n = 7, p = 0.001), as did treatment with the scaffolding domain mutant cavnoxin (1 μM) (82 ± 7% n = 7, p = 0.04). …”
  10. 44930
  11. 44931
  12. 44932
  13. 44933
  14. 44934

    Influence of Sample Stability on Non-target Analysis during Long Batch Acquisitions by Bastian Schulze (9754985)

    Published 2023
    “…The sample remained in the cooled autosampler and was re-analyzed 47 times over 24 h and daily over the following 5 days (<i>n</i> = 15 data points). Detected features were classified as “formed,” “increased,” “unchanged,” “decreased,” or “eliminated.” …”
  15. 44935
  16. 44936
  17. 44937

    Tailoring optical absorption in silicon nanostructures from UV to visible light: A TDDFT study by Hassan, Walid M.I.

    Published 2016
    “…(ii) The exciton binding energy is seen to decrease by approximately 45% from 0.67 eV to about 0.3 eV with length increase, for a nanostructure with a cross-section diameter of approximately 12 Å. …”
    Get full text
    Get full text
  18. 44938
  19. 44939
  20. 44940

    Patient interest in participating in care tasks. by Chava Kurtz (21519468)

    Published 2025
    “…</p><p>Methods</p><p>Patient interest and participation were assessed using a Likert-type scale. Associations were tested with bi-variate analysis and logistic regression, accounting for hemodialysis unit type.…”